| |
Overall survival
|
Disease-free survival
|
---|
| |
HR (95% CI)
|
p
|
HR (95% CI)
|
p
|
---|
Anastomotic leakage
|
No
|
1 (reference)
|
1 (reference)
|
Yes
|
1.53 (1.01–2.32)
|
0.041
|
1.51 (1.05–2.19)
|
0.026
|
Stage of disease
|
I
|
1 (reference)
|
1 (reference)
|
II
|
1.26 (0.72–2.20)
|
0.403
|
1.52 (0.93–2.48)
|
0.090
|
III
|
2.28 (1.38–3.78)
|
0.001
|
2.94 (1.88–4.59)
|
0.001
|
IV
|
5.87 (3.26–10.56)
|
0.001
|
6.04 (3.51–10.38)
|
0.001
|
Gender
|
Male
|
1 (reference)
|
1 (reference)
|
Female
|
1.03 (0.76–1.39)
|
0.832
|
0.95 (0.73–1.23)
|
0.714
|
Age (years)
|
≤ 55
|
1 (reference)
|
1 (reference)
|
56–70
|
1.15 (0.71–1.85)
|
0.566
|
1.02 (0.70–1.49)
|
0.889
|
≥ 71
|
1.90 (1.16–3.11)
|
0.010
|
1.15 (0.76-1.73)
|
0.498
|
Comorbidities by CCI
|
0–5
|
1 (reference)
|
1 (reference)
|
≥ 6
|
2.48 (1.64–3.74)
|
0.001
|
2.14 (1.48–3.10)
|
0.001
|
- CCI Charlson comorbidity index score